• / Free eNewsletters & Magazine
  • / My Account

High Risk

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Global Wet Age Related Macular Degeneration (AMD) Market Analysis & Outlook 2017-2021 - Research and Markets

    Global Wet Age Related Macular Degeneration (AMD) Market Analysis & Outlook 2017-2021 - Research and Markets

  2. China FDA Approves Country’s First All-Oral Regimen for Chronic Hepatitis C, Daklinza® (daclatasvir) in Combination with Sunvepra® (asunaprevir)

    China FDA Approves Country’s First All-Oral Regimen for Chronic Hepatitis C, Daklinza® (daclatasvir) in Combination with Sunvepra® (asunaprevir)

  3. Is inflation hotter than the market will admit? Bond panel can't quite agree

    Is inflation hotter than the market will admit? Bond panel can't quite agree

  4. One Day Senior Managers Regime Course (Central London, United Kingdom - June 28, 2017) - Research and Markets

    One Day Senior Managers Regime Course (Central London, United Kingdom - June 28, 2017) - Research and Markets

  5. Arsanis Completes $45.5 Million Series D Financing

    Arsanis Completes $45.5 Million Series D Financing

  6. Ipsen Reports Strong First Quarter 2017 Sales Growth of 19,1%1

    Ipsen Reports Strong First Quarter 2017 Sales Growth of 19,1%1

  7. Engaged Capital Exposes Rent-A-Center Board’s Latest Attempt to Use Corporate Machinery as an Entrenchment Tactic

    Engaged Capital Exposes Rent-A-Center Board’s Latest Attempt to Use Corporate Machinery as an Entrenchment Tactic

  8. Maury Regional Health Goes Live with Lightbeam Health Solutions

    Maury Regional Health Goes Live with Lightbeam Health Solutions

  9. UPDATE: Lyme disease is threatening an unprecedented 2017

    UPDATE: Lyme disease is threatening an unprecedented 2017

  10. Butterfield Reports First Quarter 2017 Results

    Butterfield Reports First Quarter 2017 Results

12345

©2017 Morningstar Advisor. All right reserved.